Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to implement and more cost-effective than reactive pharmacogenomic testing if a sufficient number of medications are covered by a single test and future medication exposure can be anticipated. We analysed the incidence of ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Samwald, Matthias, Xu, Hong, Blagec, Kathrin, Empey, Philip E., Malone, Daniel C., Ahmed, Seid Mussa, Ryan, Patrick, Hofer, Sebastian, Boyce, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072717/
https://www.ncbi.nlm.nih.gov/pubmed/27764192
http://dx.doi.org/10.1371/journal.pone.0164972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072717/
https://www.ncbi.nlm.nih.gov/pubmed/27764192
http://dx.doi.org/10.1371/journal.pone.0164972

Ejemplares similares